4//SEC Filing
Domzalski David 4
Accession 0001727794-25-000003
CIK 0001566044other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:05 PM ET
Size
5.1 KB
Accession
0001727794-25-000003
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2025-09-30$0.34/sh−12,676$4,246→ 428,892 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727794
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:05 PM ET
- Size
- 5.1 KB